A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
Merck Sharp & Dohme LLC
Vyriad, Inc.
Corcept Therapeutics
Taizhou Hanzhong biomedical co. LTD